A method and apparatus for spectrophotometric in vivo monitoring of blood metabolites such as hemoglobin oxygen concentration at a plurality of different areas or regions on the same organ or test site on an ongoing basis, by applying a plurality of spectrophotometric sensors to a test subject at each of a corresponding plurality of testing sites and coupling each such sensor to a control and processing station, operating each of said sensors to spectrophotometrically irradiate a particular region within the test subject; detecting and receiving the light energy resulting from said spectrophotometric irradiation for each such region and conveying corresponding signals to said control and processing station, analyzing said conveyed signals to determine preselected blood metabolite data, and visually displaying the data so determined for each of a plurality of said areas or regions in a comparative manner.
|
0. 60. A method for evaluating oxygen saturation levels in a tissue region of a human, the method comprising:
detecting, with a first detector, at least two different wavelengths of a light propagated from a transmitter through the tissue region, the transmitter being located a first distance from the first detector;
detecting, with a second detector, at least two different wavelengths of the light propagated from the transmitter through the tissue region, the second detector being located a distance from the transmitter greater than the first distance;
detecting, with a third detector, at least two different wavelengths of the light propagated from the transmitter through the tissue region, the third detector being located a distance from the transmitter greater than the first distance;
generating, with the first detector, the second detector, and the third detector, a set of signals associated with the light detected by the first detector, the second detector, and the third detector;
receiving, with an oximeter unit, the set of signals; and
determining, with the oximeter unit, at least a regional blood oxygen saturation value for the tissue region based at least in part on the set of signals.
0. 50. A system for evaluating oxygen saturation levels in a region of human tissue, the system comprising:
a transmitter, a first detector, a second detector, and a third detector, the transmitter being adapted to transmit light having at least two different wavelengths into the region of human tissue;
the first detector forming a near detector grouping with the transmitter, the first detector being adapted to detect the at least two different wavelengths of the light transmitted by the transmitter;
the second detector and the third detector each being adapted to detect the at least two different wavelengths of the light transmitted by the transmitter, the second detector and the third detector each being located farther from the transmitter than the first detector to form far detector groupings;
the first detector, the second detector, and the third detector being configured to produce a set of signals indicative of the light detected by the first detector, the second detector, and the third detector; and
an oximeter unit configured to receive the set of signals and to determine at least a regional blood oxygen saturation value for the region of human tissue based at least in part on the set of signals.
0. 66. A regional oximeter system comprising:
a first transmitter, a first detector, a second detector, and a third detector;
the first transmitter being adapted to transmit at least a first light having at least four different wavelengths into a first tissue region;
the first detector forming a near detector grouping with the first transmitter, the first detector being configured to detect the at least four different wavelengths of the first light;
the second detector and the third detector each being configured to detect the at least four different wavelengths of the first light, the second detector and the third detector each being located farther from the first transmitter than the first detector to form far detector groupings with the first transmitter; and
the first detector, the second detector, and the third detector being configured to produce a first set of signals indicative of the first light detected by the first detector, the second detector, and the third detector;
a second transmitter, a fourth detector, a fifth detector, and a sixth detector;
the second transmitter being adapted to transmit at least a second light having at least four different wavelengths into a second tissue region;
the fourth detector forming a near detector grouping with the second transmitter, the fourth detector being configured to detect the at least four different wavelengths of the second light;
the fifth detector and the sixth detector each being configured to detect the at least four different wavelengths of the second light, the fifth detector and the sixth detector each being located farther from the second transmitter than the fourth detector to form far detector groupings with the second transmitter; and
the fourth detector, the fifth detector, and the sixth detector being configured to produce a second set of signals indicative of the second light detected by the fourth detector, the fifth detector, and the sixth detector;
a first pre-amp unit configured to condition the first set of signals produced by the first sensor;
a second pre-amp unit configured to condition the second set of signals produced by the second sensor;
a processor configured to receive the conditioned first set of signals from the first pre-amp and the conditioned second set of signals from the second pre-amp and to process those signals to determine regional oxygen saturation values for the first tissue region and for the second tissue region; and
a display configured to receive the regional oxygen saturation values for the first and second tissue regions from the processor and to simultaneously display numerical indicators for those values.
0. 1. A method for comparative spectrophotometric in vivo monitoring and display of selected blood metabolites present in a plurality of different internal regions of the same test subject on a continuing and substantially concurrent basis, comprising the steps of:
applying separate spectrophotometric sensors to a test subject at each of a plurality of separate testing sites and coupling each of said sensors to a control and processing station;
operating a selected number of said sensors on a substantially concurrent basis to spectrophotometrically irradiate at least two separate internal regions of the test subject during a common time interval, each of said regions being associated with a different of said testing sites;
separately detecting and receiving light energy resulting from said spectrophotometric irradiation for each of said at least two separate internal regions, and conveying separate sets of signals to said control and processing station which correspond to the separately detected light energy from said at least two separate internal regions;
separately and concurrently analyzing said conveyed separate sets of signals to separately determine quantified data representative of a blood metabolite in each of said at least two separate internal regions; and
concurrently visually displaying said separately determined quantified data for each of said at least two separate internal regions for direct concurrent mutual comparison, wherein said sensors are applied to a head of the test subject and are used to monitor two mutually separate regions within a brain of the test subject.
0. 2. The method of
0. 3. The method of
0. 4. The method of
0. 5. The method of
0. 6. The method of
0. 7. The method of
0. 8. The method of
0. 9. The method of
0. 10. The method of
0. 11. An apparatus for concurrent comparative spectrophotometric in vivo monitoring of selected blood metabolites present in each of a plurality of different internal regions on a continuing basis, comprising:
a plurality of spectrophotometric sensors, each attachable to a test subject at different test locations and adapted to separately but concurrently spectrophotometrically irradiate at least two different internal regions within the test subject associated with each of said test locations;
a controller and circuitry coupling each of said sensors to said controller for separately and individually but concurrently operating certain of said sensors to spectrophotometrically irradiate each of said different internal regions within the test subject associated with each of said test locations;
said sensors each further adapted to receive light energy resulting from the separate spectrophotometric irradiation of said sensors' associated one of said at least two different internal regions on a substantially concurrent basis with other said sensors, and to produce separate signals corresponding to the light energy received, said circuitry acting to convey said separate signals to said controller for separate analytic processing;
said controller adapted to analytically process said conveyed signals separately and determine separate quantified blood metabolite data therefrom for each of said sensors and said sensors' associated one of said at least two different internal regions; and
a visual display coupled to said controller and adapted to separately but concurrently display the quantified blood metabolite data determined for each of said sensors in a mutually-comparative manner, wherein said sensors are adapted to be applied to a head of the test subject and to monitor a brain of the test subject.
0. 12. The apparatus of
0. 13. The apparatus of
0. 14. The apparatus of
0. 15. The apparatus of
0. 16. The apparatus of
0. 17. The apparatus of
0. 18. The apparatus of
0. 19. The apparatus of
0. 20. The apparatus of
0. 21. The apparatus of
0. 22. The apparatus of
0. 23. The apparatus of
0. 24. The apparatus of
0. 25. The apparatus of
0. 26. A method for concurrent comparative in vivo monitoring of blood metabolites in each of a plurality of different internal regions in a selected test subject, comprising the steps of:
spectrophotometrically irradiating each of a plurality of different testing sites on said test subject;
detecting light energy resulting from said spectrophotometric irradiation of said testing sites, and providing separate sets of signals to a control and processing station which are representative of the light energy received by each of said testing sites and which cooperatively define blood metabolite data for an individual one of at least two different internal regions;
analyzing said separate signals to determine quantified blood metabolite data representative of at least one defined region within said at least one test subject associated with each of at least two different of said testing sites, each said defined region being different from the other; and
concurrently displaying data sets for each of said at least two different internal regions at substantially the same time for direct mutual comparison, wherein said at least two different internal regions are located within different brain hemispheres of said test subject.
0. 27. The method of
0. 28. The method of
0. 29. The method of
0. 30. The method of
0. 31. The method of
0. 32. The method of
0. 33. The method of
0. 34. The method of
0. 35. Apparatus for spectrophotometric in vivo monitoring of a selected metabolic condition in each of a plurality of different test subject regions on a substantially concurrent basis, comprising:
a plurality of spectrophotometric emitters, each adapted to separately spectrophotometrically irradiate a designated region within a test subject from a test location on said test subject;
a controller and circuitry coupling each of said emitters to said controller for individually operating selected ones of said emitters to spectrophotometrically irradiate at least two particular regions within the test subject;
a plurality of detectors, each adapted to separately receive light energy resulting from the spectrophotometric irradiation of said at least two particular regions, and to produce at least one separate set of signals for each one of said at least two particular regions; and circuitry acting to convey said at least one separate set of signals to said controller for analytic processing;
said controller adapted to analytically process said at least one separate set of signals to determine separate sets of quantified data representative of a metabolic condition in said at least two particular regions; and
a visual display coupled to said controller and adapted to display separate representations of said separate sets of quantified data for each of said at least two particular regions in a mutually-comparative manner and on a substantially concurrent basis, wherein at least two of said at least two particular regions are located in mutually separate regions of a brain of said test subject.
0. 36. The apparatus of
0. 37. The apparatus of
0. 38. The apparatus of
0. 39. The apparatus of
0. 40. The apparatus of
0. 41. The apparatus of
0. 42. The apparatus of
0. 43. The apparatus of
0. 44. The apparatus of
0. 45. The apparatus of
0. 46. The apparatus of
0. 47. The apparatus of
0. 48. The apparatus of
0. 49. The apparatus of
0. 51. The system of claim 50, wherein a line passing through a midpoint of the transmitter and a midpoint of the first detector is spaced apart from a midpoint of the second detector and a midpoint of the third detector.
0. 52. The system of claim 50, wherein a line defined between a center of the transmitter and a center of the first detector forms an acute angle with a line defined between the center of the transmitter and a center of the second detector.
0. 53. The system of claim 52, wherein the acute angle is a first acute angle, the line defined between the center of the transmitter and the center of the first detector forms a second acute angle with a line defined between the center of the transmitter and a center of the third detector, and the second acute angle is substantially similar to the first acute angle.
0. 54. The system of claim 50, wherein the light transmitted by the transmitter has at least four different wavelengths and the first, second, and third detectors are adapted to detect each of the wavelengths.
0. 55. The system of claim 50, wherein the light is a first light, the transmitter is a first transmitter, the set of signals is a first set of signals, the region of tissue is a first region of tissue, and the regional blood oxygen saturation value is a first regional blood oxygen saturation value, the system further comprising:
a second transmitter, a fourth detector, a fifth detector, and a sixth detector, the second transmitter being adapted to transmit a second light having at least two different wavelengths into a second region of human tissue;
the fourth detector forming a near detector grouping with the second transmitter, the fourth detector being adapted to detect the at least two different wavelengths of the second light transmitted by the second transmitter;
the fifth detector and the sixth detector each being adapted to detect the at least two different wavelengths of the second light transmitted by the second transmitter, the fifth detector and the sixth detector each being located farther from the second transmitter than the fourth detector to form far detector groupings;
the fourth detector, the fifth detector, and the sixth detector being configured to produce a second set of signals indicative of the second light detected by the fourth detector, the fifth detector, and the sixth detector; and
the oximeter unit being configured to receive the second set of signals and to determine at least a second regional blood oxygen saturation value for the second region of tissue based at least in part on the second set of signals.
0. 56. The system of claim 55, wherein the oximeter unit includes a display configured to convey one or more superimposed trace lines indicative of at least the first regional blood oxygen saturation value and the second regional blood oxygen saturation value over a time period.
0. 57. The system of claim 50, wherein the oximeter unit is adapted to interconnect to a remote device for downloading data using a data output interface.
0. 58. The system of claim 50, wherein the oximeter unit includes a processor configured to transmit timing signals to cause the transmitter to transmit the light.
0. 59. The system of claim 58, further comprising a pre-amp configured to condition the set of signals before transmitting the conditioned set of signals to the oximeter, the pre-amp being configured to condition the set of signals using timing signals from the processor of the oximeter unit.
0. 61. The method of claim 60, wherein the light is a first light, the tissue region is a first tissue region, the transmitter is a first transmitter, and the regional blood oxygen saturation value is a first regional blood oxygen saturation value, the method further comprising:
detecting, with a fourth detector, at least two different wavelengths of a second light propagated from a second transmitter through a second tissue region, the fourth transmitter being located a second distance from the second transmitter;
detecting, with a fifth detector, at least two different wavelengths of the second light propagated from the second transmitter through the second tissue region, the fifth detector being located a distance from the second transmitter greater than the second distance;
detecting, with a sixth detector, at least two different wavelengths of the second light propagated from the second transmitter through the second tissue region, the sixth detector being located a distance from the second transmitter greater than the second distance;
generating, with the fourth detector, the fifth detector, and the sixth detector, a second set of signals associated with the second light detected by the fourth detector, the fifth detector, and the sixth detector;
receiving, with an oximeter unit, the second set of signals; and
determining, with the oximeter unit, at least a second regional blood oxygen saturation value for the second tissue region based at least in part on the second set of signals.
0. 62. The method of claim 61, wherein the first distance is approximately equal to the second distance.
0. 63. The method of claim 61, further comprising a step of substantially simultaneously displaying a first indicator of the first regional blood oxygen saturation value on a monitor of the oximeter unit and a second indicator of the second regional blood oxygen saturation value on the monitor of the oximeter unit.
0. 64. The method of claim 61, wherein the step of determining, with the oximeter unit, at least the second regional blood oxygen saturation value includes removing one or more effects attributable to a portion of the human tissue through which the second light propagates before being detected by the fourth detector.
0. 65. The method of claim 60, wherein the light detected at the first detector includes at least four different wavelengths and the first, second, and third detectors are adapted to detect each wavelength of the light.
0. 67. The regional oximeter system of claim 66, wherein the processor is further configured to produce timing signals to control the conditioning of the sets of signals by the first and second pre-amp units and to transmit the timing signals to the first pre-amp unit and to the second pre-amp unit, the first pre-amp unit and the second pre-amp unit being configured to condition the first set of signals and the second set of signals, respectively, using the timing signals.
0. 68. The regional oximeter system of claim 66, wherein the first transmitter and the second transmitter are adapted to transmit the first light into the first tissue region and the second light into the second tissue region, respectively, based on timing signals from the processor that control light excitation sources for the first light and the second light.
0. 69. The regional oximeter system of claim 66, wherein the display is configured to depict the regional oxygen saturation values of the first tissue region and the second tissue region using superimposed traces and event markers.
|
andAs shown in FIGS. 11 and 12, a first emitter 624, a second emitter 626, a first detector 628, and a second detector 630 are placed over a first tissue region 632. The first emitter 624 is adapted to emit a first light into the first tissue region 632 and the second emitter 626 is adapted to emit a second light into the first tissue region 632. The first detector 628 is located a first distance 634, also referred to as the first line 634, from the first emitter 624 and is located a second distance 636, also referred to as the second line 636, from the second emitter 626. As shown in these figures, the second distance 636 is greater than the first distance 634. The second detector 630 is located a third distance 638, also referred to as the third line 638, from the first emitter 624 and is located a fourth distance 640, also referred to as the fourth line 640, from the second emitter 626. As shown in these figures, the fourth distance 640 is less than the third distance 638. The first emitter 624 is closer to the first detector 628 than the second detector 630, and the second emitter 626 is closer to the second detector 630 than the first detector 628. The third distance 638 is longer than the first distance 634 and is longer than the fourth distance 640. The second distance 636 is approximately equal to the third distance 638. The first distance 634 is approximately equal to the fourth distance 640.
As further shown in FIGS. 11 and 12, the first emitter 624, the second emitter 626, the first detector 628 and the second detector 630 are aligned within the cross-sectional plane. In addition, the second line 636 defined between the center of the first detector 628 and the center of the second emitter 626 partially overlaps with the third line 638 defined between the center of the second detector 630 and the center of the first emitter 624.
Referring now to FIG. 11, a third emitter 724, a fourth emitter 726, a third detector 728, and a fourth detector 730 are placed over a second tissue region 732. The third emitter 724 is adapted to emit a third light into the second tissue region 732 and the fourth emitter 726 is adapted to emit a fourth light into the second tissue region 732. The third detector 728 is located a fifth distance 734, also referred to as the fifth line 734, from the third emitter 724 and is located a sixth distance 736, also referred to as the sixth line 736, from the second emitter 726. The second detector 730 is located a seventh distance 738, also referred to as the seventh line 738, from the third emitter 724 and is located an eighth distance 740, also referred to as the eighth line 740, from the fourth emitter 726. As also shown in FIG. 11, the third emitter 724 is closer to the third detector 728 than the fourth detector 730, and the fourth emitter 726 is closer to the fourth detector 730 than the third detector 728. The fifth distance 734 is less than the seventh distance 738. The eighth distance 740 is less than the sixth distance 736.
As shown in FIGS. 13 and 14, the first detector 628 is adapted to detect the first light propagated over a first mean path 664 through the first tissue region 632 and to detect the second light propagated over a second mean path 666 through the first tissue region 632. The second mean path 666 has a length 667 greater than a length 665 of the first mean path 664. The second detector 630 is adapted to detect the first light propagated over a third mean path 668 through the first tissue region 632 and is adapted to detect the second light propagated over a fourth mean path 670 through the first tissue region 632. The fourth mean path 670 has a length 671 less than the length 669 of the third mean path 668. The length 665 of the first mean path 664 is substantially equivalent to the length 671 of the fourth mean path 670 and the length 669 of the third mean path 668 is substantially equivalent to the length 667 of the second mean path 666. The length 665 of the first mean path 664 is less than the length 669 of the third mean path 668 and the length 671 of the fourth mean path 670 is less than the length 667 of the second mean path 666. The second mean path 666 and the third mean 668 path overlap at a location 672 below a tissue surface of the tissue region 632. In addition, along a line 674 orthogonal to the surface of the tissue between the first detector 628 and the second detector 630, the third mean path 668 lies farther from the tissue surface than the second mean path 666. The second mean path 666 lies substantially as far from a tissue surface as the third mean path 668 at approximately a midpoint 676 between the first detector 628 and the second detector 630.
As further shown in FIGS. 13 and 14, the first emitter 624 and the first detector 628 form a first near coupling. The second detector 630 is located farther from the first emitter 624 than the first detector 628 to form a first far coupling. The second emitter 626 and the first detector 628 form a second far coupling. The second detector 630 is located closer to the second emitter 626 than the first detector 628 to form a second near coupling. The first emitter 624 is adapted to transmit the first light along the first mean path 664 through a first section 680 of the first tissue region 632. The second emitter 626 is adapted to transmit the second light along the second mean path 666 through the first section 680 of the first tissue region 632 and the fourth mean path 670 through a second section 682 of the first tissue region 632. The first emitter is adapted to transmit the first light along the third mean path 668 through the second section 682 of the first tissue region 632. The first emitter 624 and the second emitter 626 are further adapted to transmit the first light and the second light along the third mean path 668 and second mean path 666, respectively, through a third section 684 of the first tissue region 632 and to transmit the first light and the second light along the first mean path 664 and the fourth mean path 670, respectively, that substantially avoid the third section 684 of the first tissue region 632.
As shown in FIG. 13, the third detector 728 is adapted to detect the third light propagated over a fifth mean path 764 through the second tissue region 732. The third detector 728 is adapted to detect the fourth light propagated over a sixth mean path 766 through the second tissue region 732. The fourth detector 730 is adapted to detect the third light propagated over a seventh mean path 768 through the second tissue region 732. The fourth detector 730 is adapted to detect the fourth light propagated over an eighth mean path 770 through the second tissue region 732. The length 769 of the seventh mean path 768 is greater than the length 765 of the fifth mean path 764 and the length 767 of the sixth mean path 766 is greater than the length 771 of the eighth mean path 770.
As shown in FIG. 15, a first transmitter 724 (previously referred to as the third emitter 724 during the discussion of FIGS. 11 and 13 above), a first detector 826, a second detector 828, and a third detector 830 are placed over a first region of tissue 732 (previously referred to as the second tissue region 732 during the discussion of FIGS. 11 and 13 above). The first transmitter 724 is adapted to transmit light into the first region of tissue 732. The first detector 826 forms a near detector grouping with the first transmitter 724. The second detector 828 and the third detector 830 are located farther from the first transmitter 724 than the first detector 826 to form far detector groupings. As also shown in FIG. 15, a line 840 passing through a midpoint of the first transmitter 724 and a midpoint of the first detector 826 is spaced apart from a midpoint of the second detector 828 and a midpoint of the third detector 830. In addition, the line 840 defined between a center of the first transmitter 724 and the center of the first detector 826 forms an acute angle 842 with a line 844 defined between the center of the transmitter 724 and a center of the second detector 828. The line 840 defined between the center of the first transmitter 724 and the center of the first detector 826 forms a second acute angle 846 with a line 848 defined between the center of the transmitter 724 and a center of the third detector 830, with the second acute angle 846 substantially similar to the first acute angle 842.
As further shown in FIG. 15, a second transmitter 624 (previously referred to as the first emitter 624 during the discussion of FIGS. 11-14 above), a fourth detector 628 (previously referred to as the first detector 628 during the discussion of FIGS. 11-14 above), a fifth detector 928, and a sixth detector 930 are placed over a second region of tissue 632 (previously referred to as the first tissue region 632 during the discussion of FIGS. 11-14 above). The fourth detector 628 forms a near detector grouping with the second transmitter 624. The fifth detector 928 and the sixth detector 930 are each located farther from the second transmitter 624 than the fourth detector 628 to form far detector groupings. As shown in FIG. 15, the distance 940 between the first transmitter 724 and the first detector 826 is approximately equal to the distance 942 between the second transmitter 624 and the fourth detector 628.
As will be understood, the foregoing disclosure and attached drawings are directed to a single preferred embodiment of the invention for purposes of illustration; however, it should be understood that variations and modifications of this particular embodiment may well occur to those skilled in the art after considering this disclosure, and that all such variations etc., should be considered an integral part of the underlying invention, especially in regard to particular shapes, configurations, component choices and variations in structural and system features. Accordingly, it is to be understood that the particular components and structures, etc. shown in the drawings and described above are merely for illustrative purposes and should not be used to limit the scope of the invention, which is defined by the following claims as interpreted according to the principles of patent law, including the doctrine of equivalents.
Scheuing, Richard S., Barrett, Bruce J., Gonopolsky, Oleg
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
4281645, | Jun 28 1977 | Duke University, Inc. | Method and apparatus for monitoring metabolism in body organs |
4321930, | Jun 28 1977 | Duke University, Inc. | Apparatus for monitoring metabolism in body organs |
4510938, | Aug 03 1981 | Duke University, Inc. | Body-mounted light source-detector apparatus |
4570638, | Oct 14 1983 | Somanetics Corporation | Method and apparatus for spectral transmissibility examination and analysis |
4725147, | Sep 17 1984 | SOMANETICS CORPORATION, A CORP OF MICHIGAN | Calibration method and apparatus for optical-response tissue-examination instrument |
4768516, | Oct 14 1983 | Somanetics Corporation | Method and apparatus for in vivo evaluation of tissue composition |
4817623, | Oct 14 1983 | Somanetics Corporation | Method and apparatus for interpreting optical response data |
4910404, | Feb 17 1988 | Sumitomo Electric Industries, Ltd. | CT computed tomograph |
5088493, | Aug 07 1984 | Sclavo, S.p.A. | Multiple wavelength light photometer for non-invasive monitoring |
5139025, | Oct 14 1983 | SOMANETICS CORPORATION A CORPORATION OF MI | Method and apparatus for in vivo optical spectroscopic examination |
5140989, | Oct 14 1983 | SOMANETICS CORPORATION, 1179 CHICAGO ROAD, TROY, MICHIGAN 48084, A CORP OF MICHIGAN | Examination instrument for optical-response diagnostic apparatus |
5190039, | Dec 08 1989 | Hitachi, Ltd. | Apparatus and method for monitoring body organs |
5217013, | Oct 14 1983 | Somanetics Corporation | Patient sensor for optical cerebral oximeter and the like |
5465714, | May 20 1993 | Nellcor Puritan Bennett LLC | Electro-optical sensor for spectrophotometric medical devices |
5477853, | Dec 01 1992 | Nellcor Puritan Bennett LLC | Temperature compensation method and apparatus for spectroscopic devices |
5482034, | May 28 1993 | Nellcor Puritan Bennett LLC | Method and apparatus for spectrophotometric cerebral oximetry and the like |
5537209, | Jan 14 1994 | SPARTA, INC | An interferometric measuring system having temperature compensation and improved optical configurations |
5539201, | Mar 14 1994 | KLEINKNECHT ELECTRIC COMPANY, INC , A NEW YORK CORPORATION | Multiple channel driver for fiber optic coupled sensors and switches |
5542421, | Jul 31 1992 | Frederick Erdman Association | Method and apparatus for cardiovascular diagnosis |
5584296, | Dec 01 1992 | Nellcor Puritan Bennett LLC | Patient sensor for optical cerebral oximeters and the like |
5661302, | Aug 24 1995 | GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC ; CRITIKON COMPANY, L L C | Method of quatitatively determining one or more characteristics of a substance |
5697367, | Oct 14 1994 | Nellcor Puritan Bennett LLC | Specially grounded sensor for clinical spectrophotometric procedures |
5779631, | Nov 02 1988 | NON-INVASIVE TECHNOLOGY, INC | Spectrophotometer for measuring the metabolic condition of a subject |
5787887, | Nov 24 1993 | Siemens Aktiengesellschaft | Apparatus for tissue examination using bidirectional transirradiation with light |
5803909, | Oct 06 1994 | Hitachi, Ltd. | Optical system for measuring metabolism in a body and imaging method |
5853370, | Sep 13 1996 | NON-INVASIVE TECHNOLOGY, INC | Optical system and method for non-invasive imaging of biological tissue |
5873821, | May 18 1992 | NON-INVASIVE TECHNOLOGY, INC | Lateralization spectrophotometer |
5902235, | Mar 29 1989 | Somanetics Corporation | Optical cerebral oximeter |
5954053, | Jun 06 1995 | NON-INVASIVE TECHNOLOGY, INC | Detection of brain hematoma |
5974337, | May 23 1995 | Method and apparatus for rapid non-invasive determination of blood composition parameters | |
5987351, | Jan 03 1995 | NON-INVASIVE TECHNOLOGY, INC | Optical coupler for in vivo examination of biological tissue |
6128517, | Oct 06 1994 | Hitachi, Ltd. | Optical system for measuring metabolism in a body and imaging method |
6240309, | Oct 06 1995 | Hitachi, Ltd. | Optical measurement instrument for living body |
6282438, | Oct 06 1994 | Hitachi, Ltd. | Optical system for measuring metabolism in a body and imaging method |
6334065, | May 27 1999 | JPMorgan Chase Bank, National Association | Stereo pulse oximeter |
6397099, | May 18 1992 | Non-Invasive Technology, Inc. | Non-invasive imaging of biological tissue |
6549795, | May 16 1991 | NON-INVASIVE TECHNOLOGY, INC | Spectrophotometer for tissue examination |
6615065, | Oct 13 1998 | Covidien LP | Multi-channel non-invasive tissue oximeter |
RE44735, | Oct 13 1998 | Nellcor Puritan Bennett LLC | Multi-channel non-invasive tissue oximeter |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 28 2013 | Covidien LP | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Jul 14 2018 | 4 years fee payment window open |
Jan 14 2019 | 6 months grace period start (w surcharge) |
Jul 14 2019 | patent expiry (for year 4) |
Jul 14 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 14 2022 | 8 years fee payment window open |
Jan 14 2023 | 6 months grace period start (w surcharge) |
Jul 14 2023 | patent expiry (for year 8) |
Jul 14 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 14 2026 | 12 years fee payment window open |
Jan 14 2027 | 6 months grace period start (w surcharge) |
Jul 14 2027 | patent expiry (for year 12) |
Jul 14 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |